Association of metabolic syndrome with atherothrombotic blood phenotypes in Asian Indian families with premature coronary artery disease

Archives of Medical Science

Volumn 4, Issue 2, 2008, Pages 145-151

  Kanjilal, Saikat ^a   Shanker, Jayashree ^a   Rao, Veena S ^a   Mukherjee, Manjari ^a   Iyengar, Shamanna S ^a   Kakkar, Vijay V ^a,b  

^a THROMBOSIS RESEARCH INSTITUTE   (India)

^b THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Anthropometrics; Biomarkers; Metabolic syndrome definition

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; AUTOANALYSIS; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY STUDY; FEMALE; HUMAN; INDIAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHENOTYPE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 48249094186     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Reaven, GM, Banting Lectutre 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24: e13-8.
3. Ridker PM, Wilson BW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-25.
4. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25: 2016-21.
5. Tamakoshi K, Yatsuya H, Kondo T, et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003; 27: 443-9.
6. Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 2002: 32 (Suppl 3): 24-34.
7. Mc Laughlin T, Abbasi F, Lamendola C, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002; 106: 2908-12.
8. Tomai F. C reactive protein and microvascular function. Heart 2004; 90: 727-8.
9. Gómez Rosso L, Benítez MB, Fornari MC, et al. Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome. Atherosclerosis 2007 Dec 18 [Epub ahead of print].
10. Anand SS, Yi Q, Gerstein H, et al.; Study of Health Assessment and Risk in Ethnic Groups; Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-5.
11. Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes and consequences. Arterioscler Thromb Vasc Biol 2006; 26: 2200-7.
12. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
13. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, World Health Org., 1999.
14. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Current Science 2002; (Special Section: Diabetes) 12: 1483-96.
15. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Carribeans, and white Europeans: a UK population based cross sectional study. Diabetologia 2005; 48: 649-56.
16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
17. International Diabetes Federation. Rationale for new IDF worldwide definition of metabolicsyndrome. Available at: http://www.idf.org/webdata/docs/ metabolic_syndrome_rationale.pdf.
18. Snehalatha C, Vishwanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003; 26: 1380-4.
19. Misra A, Wasir JS, Pandey RM. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care 2005; 28: 398-403.
20. Heng D, Ma S, Lee JJ, et al. Modification of the NCEP ATPIII definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis 2006; 186: 367-73.
21. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-6.
22. Enas EA. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Medical Assoc 2000; 98: 694-5, 697-702.
23. Hughes K, Aw TC, Kuperan P, Choo M. Central Obesity, insulin resistance, syndrome X, Lp(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1996; 51: 394-9.
24. Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Prospective data from the Bruneck study. Diabetes Care 2003; 26: 1251-7.
25. Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. BMI does not accurately predict overweight in Asian Indians in northern India Br J Nutr 2001; 86: 105-12.
26. Thomas CS, Krishnaswami S. Distribution of body mass index in Indian patients with coronary artery disease. Indian Heart J 1995; 47: 134-7.
27. Kowalski J, Barylski M, Godala M, Irzmanski R, Brocka E, Pawlicki L. Estimation of cardiovascular complications and death risk in subjects with metabolic syndrome. Arch Med Sci 2006; 4: 252-5.
28. Wranicz JK, Cygankiewicz I, Kula P, Walczak-Jedrzejowska, Slowikowska-Hilczer J, Kula K. Cardiovascular and metabolic effects of estrogen in men. Arch Med Sci 2006; 4: 221-5.
29. Kurpad SS, Tandon H, Srinivasan K. Waist circumference correlates better with body mass index than waist to hip ratio in Asian Indians. Natl Med J India 2003; 16: 89-192.
30. Ritchie SA, Evart M, Perry CG, Connell JM, Salt IP. The role of insulin and adipocytokines in regulation of vascular endothelial function. Clin Sci 2004; 107: 519-32.
31. Liang X, Kanjanabuch T, Mao SL, et al. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab 2006; 290: E103-13.
32. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K. Correlations of C-reactive protein with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban northern India Atherosclerosis 2003; 168: 305-13.
33. Smith J, Al-Amri M, Sniderman A, Cianflone K. Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutr Metab (Lond) 2006; 3: 18.
34. Shamsuzzaman AS, Winnicki M, Wolk R, et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004; 109: 2181-5.
35. Tsuda K, Kimura K, Nishio I. Leptin improves membrane fluidity of erythrocytes in human via nitric oxide dependent mechanism: an electron paramagnetic resonance investigation. Biochem Biophys Res Commun 2002; 297: 672-81.